0.25%
-32.89%
-28.92%
-25.41%
6.11%
163.23%
149.39%
AI Spotlight on MCAP
Company Description
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout.It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies.The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe.
It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million).The firm seeks to acquire stakes between 20% and 50% in its portfolio companies.It uses its capital and loans and makes balance sheet investments.
MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.
Market Data
| Last Price | 408 |
| Change Percentage | 0.25% |
| Open | 407 |
| Previous Close | 407 |
| Market Cap ( Millions) | 6109 |
| Volume | 37845 |
| Year High | 632 |
| Year Low | 358 |
| M A 50 | 539.73 |
| M A 200 | 527.06 |
Financial Ratios
| FCF Yield | 4.10% |
| Dividend Yield | 0.00% |
| ROE | 20.45% |
| Debt / Equity | 29.13% |
| Net Debt / EBIDTA | 14.65% |
| Price To Book | 5.06 |
| Price Earnings Ratio | 26.51 |
| Price To FCF | 24.4 |
| Price To sales | 3.41 |
| EV / EBITDA | 15.11 |
News
- Jan -31 - Uncovering 3 Promising Small Cap Gems With Solid Foundations
- Dec -16 - Undiscovered Gems with Strong Potential for December 2024
- Oct -21 - Undiscovered Gems In Sweden October 2024
- Aug -02 - Unveiling 3 Undiscovered Gems In Sweden With Strong Potential
- Aug -01 - Exploring 3 Undiscovered Swedish Gems with Strong Fundamentals
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Aid
Expected Growth : 8 %
What the company do ?
Aid from MedCap AB (publ) provides financing solutions to healthcare providers, enabling them to focus on patient care while improving their financial stability.
Why we expect these perspectives ?
Aid from MedCap AB (publ) with 8% growth driven by increasing demand for medical devices, strategic partnerships, and expansion into emerging markets. Additionally, investments in R&D, cost savings initiatives, and favorable regulatory environments contribute to the growth momentum.
Segment n°2 -> Medical Technology
Expected Growth : 12 %
What the company do ?
Medical Technology from MedCap AB (publ) develops innovative medical devices and solutions for healthcare professionals and patients, improving patient outcomes and quality of life.
Why we expect these perspectives ?
MedCap AB's 12% growth in Medical Technology is driven by increasing demand for innovative medical devices, expanding healthcare infrastructure, and an aging population. Additionally, advancements in digital health, AI, and data analytics are fueling growth. Strategic partnerships, regulatory approvals, and investments in R&D are also contributing to the company's rapid expansion.
Segment n°3 -> Specialist Medicines
Expected Growth : 9 %
What the company do ?
Specialist Medicines from MedCap AB (publ) develops and commercializes niche pharmaceuticals for rare and severe diseases, improving patient outcomes and quality of life.
Why we expect these perspectives ?
Strong demand for rare disease treatments, increasing prevalence of chronic conditions, and strategic partnerships drive MedCap AB's 9% growth in Specialist Medicines. Additionally, investments in R&D, expansion into emerging markets, and favorable regulatory environments contribute to the segment's rapid expansion.
Medcap Ab (Publ) Products
| Product Range | What is it ? |
|---|---|
| Medical Imaging | MedCap AB provides medical imaging solutions for hospitals and clinics, offering a range of imaging modalities including MRI, CT, and X-ray. |
| Radiation Therapy | MedCap AB offers radiation therapy solutions for cancer treatment, providing advanced technology for precise and effective treatment. |
| Patient Monitoring | MedCap AB provides patient monitoring solutions for hospitals and clinics, enabling real-time monitoring of patient vital signs and medical data. |
| Medical IT Solutions | MedCap AB offers medical IT solutions for healthcare providers, including electronic health records, practice management, and revenue cycle management. |
| Medical Consulting | MedCap AB provides medical consulting services to healthcare providers, offering expertise in medical imaging, radiation therapy, and patient monitoring. |
MedCap AB (publ)'s Porter Forces
Threat Of Substitutes
The threat of substitutes for MedCap AB (publ) is medium due to the presence of alternative medical devices and services in the market.
Bargaining Power Of Customers
The bargaining power of customers for MedCap AB (publ) is low due to the specialized nature of medical devices and services, making it difficult for customers to negotiate prices.
Bargaining Power Of Suppliers
The bargaining power of suppliers for MedCap AB (publ) is medium due to the presence of multiple suppliers of raw materials and components, but the company's dependence on a few key suppliers.
Threat Of New Entrants
The threat of new entrants for MedCap AB (publ) is high due to the growing demand for medical devices and services, making it an attractive market for new entrants.
Intensity Of Rivalry
The intensity of rivalry for MedCap AB (publ) is high due to the presence of established competitors in the market, leading to a competitive pricing strategy and high marketing expenses.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 12.11% |
| Debt Cost | 7.09% |
| Equity Weight | 87.89% |
| Equity Cost | 7.09% |
| WACC | 7.09% |
| Leverage | 13.78% |
MedCap AB (publ) : Quality Control
MedCap AB (publ) passed 8 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| MLP.DE | MLP SE, together with its subsidiaries, provides financial brokerage and consulting services to private, corporate, and institutional clients in Germany. The company's Financial Consulting segment offers consulting services for academics … |
| HBMN.SW | HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, … |
| IPO.L | IP Group Plc is a private equity and venture capital firm specializing in seed, early stage, start-up, incubation, growth capital, and mature financing. The firm also provides seed capital financing … |
| BBN.SW | Bellevue Group AG provides asset management services in Switzerland, the Great Britain, Germany, and internationally. The company offers a range of products in the areas of specialized healthcare equity, selected … |
| BRK.L | Brooks Macdonald Group plc, through its subsidiaries, provides a range of investment and wealth management services to private clients, pension funds, professional intermediaries, and trustees in the United Kingdom and … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
MLP
A-Score
1-Year Total Return ->
🥈
HBM Healthcare Investments
A-Score
1-Year Total Return ->
🥉
Bellevue
A-Score
1-Year Total Return ->
4
Brooks Macdonald
A-Score
1-Year Total Return ->
5
MedCap
A-Score
1-Year Total Return ->
6
